Women often seek alternative treatment options such as herbs, dietary supplements, and vitamins and minerals to treat women’s health issues across the lifespan. Women may use complementary and alternative supplements for dysmenorrhea, premenstrual syndrome, infertility, nausea and vomiting during pregnancy, and symptoms of menopause. In general, there is a deficit of well‐designed, randomized, controlled trials to evaluate the efficacy and safety of complementary and alternative medicine for these indications, which makes it difficult to provide evidence‐based recommendations. This review outlines the evidence for efficacy and safety that is currently available for dietary supplement use by women to manage health conditions specific to the female patient.
DennehyC. The use of herbs and dietary supplements in gynecology: an evidence‐based review. J Midwifery Womens Health. 2006;51:402‐409.
2.
EisenbergDMDavisRBEttnerS. Trends in alternative medicine use in the United States, 1990‐1997. JAMA. 1998; 280:1569‐1575.
3.
KronenbergFFugh‐BermanA. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med. 2002;137:805‐813.
4.
ProctorMFarquharC. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332:1134‐1138.
5.
FrenchL. Dysmenorrhea. Am Fam Physician. 2005;71:285‐291.
6.
RosenwaksZSeegr‐JonesG. Menstrual pain: its origin and pathogenesis. J Reprod Med. 1980;25(suppl 4):207‐212.
7.
ProctorMMurphyPA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2001;2:CD002124.
8.
SanfilippoJErbT. Evaluation and management of dysmenorrhea in adolescents. Clin Obstet Gynecol. 2008;51:257‐267.
9.
GokhaleL. Curative treatment of primary (spasmodic) dysmenorrhoea. Indian J Med Res. 1996;103:227‐231.
10.
DawoodM. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108:438‐441.
11.
ZiaeiSFaghihzadehSSohrabvandFLamyianMEmamgholyT. A randomized placebo‐controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG. 2001;108:1181‐1183.
12.
ZiaeiSZakeriMKazemnejadA. A randomized controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG. 2005;122:466‐469.
DeutchB. Menstrual pain in Danish women correlated with low n‐3 polyunsaturated fatty acid intake. Eur J Clin Nutr. 1995;49: 508‐516.
15.
HarelZBiroFKottenhahnRRosenthalS. Supplementation with omega‐3 polyunsaturated fatty acids in the management of dysmenorrheal in adolescents. Am J Obstet Gynecol. 1996;174:1335‐1338.
ACOG Committee Opinion. Premenstrual syndrome: Committee on gynecologic practice. Int J Gynaecol Obstet. 1995;50:80‐84.
18.
GirmanALeeRKliglerB. An integrative medicine approach to premenstrual syndrome. Clin J Womens Health. 2003;2:116‐127.
19.
JarvisCLynchAMorinA. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. Ann Pharmacother. 2008;42:967‐978.
20.
Thys‐JacobsSAlvirMA. Calcium‐regulating hormones across the menstrual cycle: evidence of secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab. 1995;80:2227‐2232.
21.
Thys‐JacobsSCeccarelliSBiermanAWeismanHCohenMAlvirJ. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med. 1989;4:183‐189.
22.
PenlandJJohnsonP. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol. 1993;168:1417‐1423.
23.
Thys‐JacobsSStarkeyPBernsteinDTianJ. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol. 1998;179:444‐452.
DeSouzaMWalkerARobinsonPBollandK. A synergistic effect of daily supplement for 1 month of 200mg magnesium plus 50mg vitamin B6 for the relief of anxiety‐related premenstrual symptoms: a randomized, double‐blind, crossover study. J Womens Health (Larchmt). 2000;9:131‐139.
LauritzenCHReuterHRepgesRBohnertKSchmidtU. Treatment of premenstrual tension syndrome with Vitex agnus castus: controlled, double‐blind study versus pyridoxine. Phytomedicine. 1997;4:183‐189.
40.
AtmacaMKumruSTezcanE. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacology Clin Exp. 2003;18:191‐195.
41.
BergerDSchaffnerWSchraderEMeierB. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre‐menstrual syndrome (PMS). Arch Gynecol Obstet. 2000;264:150‐153.
42.
SchellenbergR. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomized, placebo controlled study. BMJ. 2001;322:134‐137.
43.
WangWChenHSLiuJP. Evening primrose oil or other essential fatty acids for the treatment of pre‐menstrual syndrome (PMS). Cochrane Database Syst Rev. 2008;2:CD001123.
44.
BudeiriDLi Wan PoADornanJC. Is evening primrose oil of value in the treatment of premenstrual syndrome?Control Clin Trials. 1996;17:60‐68.
45.
CollinsACerinAColemanGLandgrenBM. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol. 1993;81:93‐98.
46.
PuolakkaJMakarainenLViinikkaLYlikorkalaO. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med. 1985;30:149‐153.
AgarwalAGuptaSSharmaRK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:1‐21.
49.
LuckMRJeyaseelanIScholesRA. Ascorbic acid and fertility. Biol Reprod. 1995;52:262‐266.
50.
HenmiHEndoTKitajimaYManaseKHataHKudoR. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil Steril. 2003;80:459‐461.
51.
CrhaIHrubaDVentrubaPFialaJTotusekJVisnovaH. Ascorbic acid and infertility treatment [abstract]. Cent Eur J Public Health. 2003;11:63‐67.
52.
GriesingerGFrankeKKinastC. Ascorbic acid supplement during luteal phase in IVF. J Assist Reprod Genet. 2002;19:164‐168.
53.
Roemheld‐HammB. Chasteberry. Am Fam Physician. 2005;72:821‐824.
54.
GerhardIIPatekAMongaBBlankAGorkowC. Matodynon® for female sterility [abstract in English]. Forsch Komplementarmed. 1998;5:272‐278.
55.
MilewiczAGejdelESworenH. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia: results of a randomized placebo‐controlled double‐blind study [abstract in English]. Arzneimittelforschung. 1993;43:752‐756.
56.
WestphalLMPolanMLTrantASMooneySB. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med. 2004;49:289‐293.
57.
WestphalLMPolanMLTrantAS. Double‐blind, placebo‐controlled study of FertilityBlend: a nutritional supplement for improving fertility in women. Clin Exp Obstet Gynecol. 2006;33:205‐208.
58.
GadsbyRBarnie‐AdsheadAMJaggerC. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993;43:245‐248.
59.
LacroixREasonEMelzackR. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity and patterns of change. Am J Obstet Gynecol. 2000;182:931‐937.
60.
MazzottaPStewartDAtanackovicGKorenGMageeL. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti‐emetic therapy. J Psychosom Obstet Gynaecol. 2000;21:129‐136.
61.
BadellMRaminSSmithJ. Treatment options for nausea and vomiting during pregnancy. Pharmacotherapy. 2006;26:1273‐1287.
62.
OrnsteinMEinarsonAKorenG. Bendectin/Diclectin for morning sickness: a Canadian follow‐up of an American tragedy. Reprod Toxicol. 1995;9:1‐6.
63.
KutcherJEngleAFirthJLammS. Bendectin and birth defects II: ecological analyses. Birth Defects Res A Clin Mol Teratol. 2003;67:88‐97.
64.
KorcokM. The Bendectin debate. CMAJ. 1980;123:922‐928.
65.
SchusterKBaileyLBDimperioDMahanCS. Morning sickness and vitamin B6 status of pregnant women. Hum Nutr Clin Nutr. 1985;39:75‐79.
66.
SahakianVRouseDSipesSRoseNNiebylJ. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double‐blind placebo‐controlled study. Obstet Gynecol. 1991;78:33‐36.
67.
VutyavanicTWongtra‐nganSRuangsriR. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double‐blind, placebo‐controlled trial. Am J Obstet Gynecol. 1995;173:881‐884.
68.
JewelDYoungG. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2003;4:CD000145.
69.
NelsonMMForfarJO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J. 1971;1:523‐527.
70.
ShrimABoskovicRMaltepeCNaviosYGarcia‐BournissenFKorenG. Pregnancy outcome following use of large doses of vitamin B6 in the first trimester. J Obstet Gynecol. 2006;26:749‐751.
VutyavanichTKraisarinTRuangsriRA. Ginger for nausea and vomiting in pregnancy: randomized, double‐masked, placebo‐ controlled trial. Obstet Gynecol. 2001;97:577‐582.
73.
WillettsKEkangakiAEdenJ. Effect of a ginger extract on pregnancy‐induced nausea: a randomized controlled trial. Aust N Z J Obstet Gynaecol. 2003;43:139‐144.
74.
TiranD. Nausea and vomiting in pregnancy: safety and efficacy of self‐administered complementary therapies. Complement Ther Nurs Midwifery. 2002;8:191‐196.
75.
PortnoiGChngLAKarimi‐TabeshLKorenGTanMEinarsonA. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol. 2003;189:1374‐1377.
76.
SmithCCrowtherCWillsonKHothamNMcMillianV. A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstet Gynecol. 2004;103:639‐645.
77.
SripramoteMLekhyanandaN. A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy. J Med Assoc Thai. 2003;86:846‐853.
78.
ChittummaPKaewkiattikunKWiriyasiriwachB. Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double‐blind controlled trial. J Med Assoc Thai. 2007;90:15‐20.
79.
EnsiyehJSakinehMA. Comparing ginger and vitamin B6 for the treatment of nausea and vomiting in pregnancy: a randomised controlled trial. Midwifery. In press.
80.
North American Menopause Society. Treatment of menopause‐associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause. 2004;11:11‐33.
81.
UtianWHArcherDFBachmannGA. Estrogen and progesterone use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause. 2008;15(4 pt 1):584‐602.
82.
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA. 2002;288:321‐333.
83.
HershALStefanickMLStaffordRS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291:47‐53.
84.
KrebsEEEnsrudKEMacDonaldRWiltTJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol. 2004;104:824‐836.
85.
HuntleyALErnstE. Soy for the treatment of perimenopausal symptoms: a systematic review. Maturitas. 2004;47:1‐9.
86.
KnightDCEdenJA. A review of the clinical effects of phytoestrogens. Obstet Gynecol. 1996;87:897‐904.
87.
NelsonHDVescoKKHaneyE. Nonhormonal therapies for menopausal hot flashes: systematic review and meta‐analysis. JAMA. 2006;295:2057‐2071.
NewtonKMReedSDLaCroixAZGrothausLCEhrlichKGuiltnanJ. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo. Ann Intern Med. 2006;145:869‐879.
90.
MacGregorCACanneyPAPattersonGMcDonaldRPaulJ. A randomised double blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer. 2005;41:708‐714.
91.
ZhangXShuX‐OLiH. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med. 2005;165:1890‐1895.
92.
MaDFQinLQWangPYKatohR. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta‐analysis of randomized controlled trials. Eur J Clin Nutr. 2008;62:155‐161.
93.
MaDFQinLQWangPYKatohR. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta‐analysis of randomized controlled trials. Clin Nutr. 2008;27:57‐64.
94.
HooperLKroonPARimmEB. Flavonoids, flavonoid‐rich foods, and cardiovascular risk: a meta‐analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38‐50.
95.
SacksFMLichtensteinAVan HornLHarrisWKris‐EthertonPWinstonM. Soy protein, isoflavones, and cardiovascular health: an American Heart Association science advisory for professionals from the nutrition committee. Circulation. 2006;113:1034‐1044.
96.
ManonaiJSongchitsomboonSChandaKHongJHKomindrS. The effect of a soy‐rich diet on urogenital atrophy: a randomized, cross‐over trial. Maturitas. 2006;54:135‐140.
MahadyGB. Do soy isoflavones cause endometrial hyperplasia?Nutr Rev. 2005;63:392‐397.
99.
TrockBJHilakivi‐ClarkeLClarkeR. Meta‐analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98:459‐471.
100.
MessinaMRedmondG. Effects of soy protein and soybean isoflavones on thyroid function in healthy adults and hypothyroid patients: a review of the relevant literature. Thyroid. 2006;16:249‐259.
101.
BorrelliFErnstE. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res. 2008;58:8‐14.
102.
CheemaDCoomarasamyAToukhyTE. Non‐hormonal therapy of post‐menopausal vasomotor symptoms: a structured, evidence‐based review. Arch Gynecol Obstet. 2007;276:463‐469.
JacobsonJSTroxelABEvansJ. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol. 2001;19:2739‐2745.
BrieseVStammwitzUFriedeMHenneicke‐von ZepelinHH. Black cohosh with or without St. John’s wort for symptom‐specific climacteric treatment: results of a large‐scale, controlled, observational study. Maturitas. 2007;57:405‐414.
107.
BorrelliFErnstE. Black cohosh (Cimicifuga racemosa): a systematic review of adverse effects. Am J Obstet Gynecol. 2008;199:455‐466.
108.
AntoineCLievensFCarlyBPastijnARozenbergS. Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review. Climacteric. 2007;10:23‐26.
109.
RuhlenRLHaubnerJTracyJK. Black cohosh does not exert an estrogenic effect on the breast. Nutr Cancer. 2007;59:269‐277.
110.
WaljiRBoonHGunsEOneschukDYounusJ. Black cohosh (Cimcifuga Racemosa [L.] Nutt.): safety and efficacy for cancer patients. Support Care Cancer. 2007;15:913‐921.
